Back to results
US 2003/0157158 A1Published application
Enhanced liposomal thioretinaco ozonide compositions and liposomal carrier
OwnerKilmer S. McCullyinventor
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
OwnerKilmer S. McCullyinventor
Estimating the term…
A therapeutically active composition of thioretinaco ozonide is provided for providing anticarcinogenic, antineoplastic, antiviral, antiatherogenic, and antiaging benefits having the formula: (NHTR)2CblO3O2ATP wherein: NHTR is N-homocysteine thiolactonyl retinamide; Cbl is cobalamin; O3 is ozone; O2 is oxygen; and ATP is adenosine triphosphate. The N-homocysteine thiolactonyl retinamido cobalamin ozonide oxygen adenosine triphosphate complex is further enhanced by utilizing an ozone-resistant liposomal carrier for protecting the composition against oxidative degradation. The ozone-resistant liposomal carrier is advantageously employed to protect a variety of pharmaceutical compositions from oxidative degradation. The ozone-resistant liposomal carrier can also be sterically stabilized to increase the concentration and efficiency of the delivery of pharmaceutical compositions.
A liposomal preparation comprising:
A pharmaceutical preparation having the formula:
A liposomal carrier for stabilizing medicaments susceptible to oxidative degeneration selected from the group consisting of:
A method of treating an animal with a therapeutic agent comprising:
A method of enhancing the pharmacological activities of a composition comprising:
Dependencies are inferred from the claim text.